Grapefruit Drug Interactions: a bitter juice to swallow Jeffery D. Evans. PharmD Assistant Professor of Pharmacy Practice University of Louisiana at Monroe.

Slides:



Advertisements
Similar presentations
Pages 645 to 724 Mechanisms of Drug Interaction Pharmacokinetic –Reduced rate and/or completeness of absorption –Altered bioavailabilty –Reduced.
Advertisements

Chapter 17: Institutional Pharmacy Jeffery D. Evans, Pharm.D. Associate Professor of Pharmacy Practice.
1. 2 The primary Objective of IDEAL LDL-C Simvastatin mg/d Atorvastatin 80 mg/d risk CHD In stable CHD patients IDEAL: The Incremental Decrease.
RELATIVE HEPATIC CONTENT OF CYP ENZYMES % DRUGS METABOLIZED BY CYP ENZYMES ROLE OF CYP ENZYMES IN HEPATIC DRUG METABOLISM.
Harvoni® ledipasvir/sofosbuvir
PHAR 751 Dietary Effects on Metabolism
Grapefruit -Drug Interaction: Isolation, Biological Activities of Furocoumarins and Their Variation due to Pre- and Post-harvest Factors Bhimanagouda S.
Chapter 6 Drug Interactions 1.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 25 Drug Interactions.
Drug Interactions Scott R. Penzak, Pharm.D. Pharmacokineticist
Kayla Jester April 18, 2011 Micronutrient Metabolism.
Background: Focus on P-gp Questions:
CYP2C8 and Drug Interactions
Pharmacologic Principles Chapter 1, 2, 3. Understanding Nurses must understand both + and – effects of drugs Pharmacotherapeutics –u–use of drugs and.
Lamotrigine Metabolism in the Human Placenta Lindsay Samuel Mentor: Phillip M. Gerk, PharmD, PhD Department of Pharmaceutics Joseph K. Ritter, PhD Department.
New Agents Heather Kertland, PharmD.
Post-mortem SNP analysis of CYP2D6 gene reveals correlation between genotype and opioid drug metabolite ratios in blood Levo et al. Forensic Science International.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 11 Drug Therapy in Geriatric Patients.
Pharmacokinetics (PK): What the body does to the drug? Most drugs: Enter the body by crossing barriers Distributed by the blood to the site of action Biotransform.
Drug - Food Interactions
Slide 1 EZT 2002-W-6022-SS Ezetimibe Co-administered with Statins: Efficacy and Tolerability Copyright © 2003 MSP Singapore Company, LLC. All rights reserved.
CLEARANCE (CL) describes the efficiency of irreversible elimination of a drug from the body by excretion of unchanged drug. Metabolic conversion of the.
The role of furocoumarins in grapefruit juice/drug interactions. Paul B. Watkins University of North Carolina Chapel Hill, N.C.
Grapefruit juice and the intestinal barrier in man: not pulp fiction Paul B. Watkins University of North Carolina Chapel Hill, N.C. December 2, 2003.
Praluent® - alirocumab
Lecture 2.  Clearance Ability to eliminate the drug  Volume of distribution (Vd) The measure of the apparent space in the body available to contain.
Slide 1 Downloaded from Ezetimibe Factorial Coadministration Studies.
Slide 1 EZT 2003-W SS Mechanism of Action and Pharmacology of Ezetimibe Copyright © 2003 MSP Singapore Company, LLC. All rights reserved.
Pharmacogenetics and Pharmacogenomics Eric Jorgenson 2/24/9.
Toujeo® and it’s Place in Therapy
Issues and Challenges in the Evaluation and Labeling of Drug Interaction Potentials of NME Shiew-Mei Huang, Ph.D. Deputy Office Director for Science Office.
Prepared By MARIAM SALEH ALAMRO A Calcium Channel Blocker.
Statin Induce Myotoxicity
The role of furocoumarins in grapefruit juice/drug interactions.
Sprout Pharmaceuticals Inc. FDA Approval Date: August 18, 2015
Efficacy and Comparability of Thiazide-type Diuretics
May 19, 2005FDA Antiviral Drugs Advisory Committee Meeting 1 Tipranavir NDA Drug Interactions Yuanchao (Derek) Zhang, Ph.D. Clinical Pharmacology.
© 2008 Universitair Ziekenhuis Gent PHARMACOKINETICS IN CKD R Vanholder University Hospital, Gent, Belgium.
INTRODUCTION CLINICAL PHARMACOKINETICS
Shirley M. Tsunoda Liver Transplant, Drug Metabolism/PK Research Interests Investigating the genetic and environmental factors that influence variability.
Simultaneous evaluation of the activity of five cytochrome P450 enzymes by a cocktail study in healthy volunteers Department of Pharmacy Practice & Sciences.
Metabolic Stability Lee, Sang-Hwi. -2- Overview Metabolism is the enzymatic modification of compounds to increase clearance. It is a determinant.
CYP
Manufacturer: Amgen Inc FDA Approval Date: August 27, 2015
1 The Role of Exposure-Response Evaluation in Drug Development and Regulatory Decisions Case Study: Rosuvastatin Hae-Young Ahn, Ph.D. Office of Clinical.
1 Transporters and Their Role in Drug Interactions.
415 PHT Plasma Level – Time Curve
Osphena® (ospemifene) Stefanie L Drahuschak University of Pittsburgh PharmD Candidate 2014.
Christina Howlett, Pharm.D., BCOP Assistant Clinical Professor, Ernest Mario School of Pharmacy Oncology Pharmacy Specialist, Hackensack University Medical.
Basic Concepts of Pharmacology © Paradigm Publishing, Inc.
Manufacturer: Relypsa Inc. FDA Approval Date: October 21, 2015
Epclusa® sofosbuvir/velpatasvir
Eucrisa™ - Crisaborole
Drug Discovery &Development
FOOD-Drug Interactions (FDI)
Trial profile for the pharmacokinetics and pharmacodynamics study in patients with dyslipidaemia (A) and the ambulatory blood pressure study (B) *Participants.
Pharmacokinetics.
Pharmacokinetics.
A clinician's guide to statin drug-drug interactions
Drugs, drugs, and more drugs…
Recent Advancement In Therapeutics ZURAMPIC ( LESINURAD)
GRAPEFRUITS and Drug Interactions
Senior Medical Director, Cardiovascular
Kamagra Fizz Usage, Dosage, Composition. Summary Kamagra is the generic form of the brand Viagra. It contains sildenafil citrate as the active component.
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Why double blind, controlled randomized trials?
Lurasidone Flavio Guzmán, MD.
Drug - Food Interactions
Major classes of drugs to reduce lipids
Pharmacology The science of Drugs.
Presentation transcript:

Grapefruit Drug Interactions: a bitter juice to swallow Jeffery D. Evans. PharmD Assistant Professor of Pharmacy Practice University of Louisiana at Monroe in Shreveport

Objectives At the end of this presentation the audience member should be able to – Understand and apply drug – food interactions, specifically grapefruit juice, to patient care – Identify commonly prescribed drugs that may have issues if taken with grapefruit juice

Full Disclosure I am from here Grapefruit comes from here

The beginning Felodipine (Plendil) was being studied – Concerns arose there was an interaction with ethanol. – Single blind trial was setup Placebo group got a non-alcoholic drink ‘Active’ got one shot of vodka However there was a clear difference in taste

The effect Both groups had – Several fold higher concentrations of felodipine – Significantly lower BP – Significantly more adverse effects What could be causing this?

Effects of GFJ on felodipine

Systolic BP variance Wilkinson GR N Engl J Med 2005; 352:

Diastolic BP Variance Wilkinson GR N Engl J Med 2005; 352:

Viagra and Grapefruit juice Viagra + GFJ Viagra + water Jeter A et al. Clinical Pharmacol Ther 2002 Jan; 71(1):21-9

Potential Causes for Drug-Food Interactions Gut transit time – Delayed vs accelerated gastric emptying Enzyme manipulation Transporter activity changes

Potential Mechanisms of Action Inactivation of Cyp 3A4 – In the gut – In the liver Not just inactivation – CYP3A4 mRNA decreases after GFJ – Possible degradation of the enzyme

Potential Mechanisms of Action P-Glycoprotein (P-gp) – A drug transporter – Found where 3A4 is – Excretes drugs back into the lumen Organic Anion Transfer Protein (OATP) – Another drug transporter – Not much is known, but data shows GFJ impact

Effects of GFJ on Felodipine

What is to blame for effects? Naringin – A flavonoid – Not found in other fruit juices – In vitro data shows inhibition effects – In vivo data does not show effects Quesrcetin Kaempferol X

What is to blame for effects? Furanocoumarins (psoralens) – Bergamottin Time dependent Cyp inactivation Concentration dependent Cyp inactivation – Others found in GFJ also inactivate CYP

Duration of effect Separating the dose of medication and GFJ prevents effects. – No, not really First dose seems to have the same effect as last dose of GFJ Effects seen as far out as seven days

So does it really matter Yes and Maybe 29 year old man – Stable with terfenadine 60 mg BID x 1 year – Consumed two glasses of GFJ – Collapsed and died – Had toxic levels of terfenadine Spence et al Clin Pharmacol Ther 61,

Can they help Cyclosporine was a significant expense – Undergoes 3A4 metabolism in the gut – Transported by P-gp – GFJ increased AUC by 60% – Allowing for reduction in doses Yee et al Lancet 1995; 345:

Resources for GFJ interactions Center for Food-Drug Interaction Research and Education – Maintained by the University of Florida – Provides information for consumers and HCPs –

Significant Interactions with GFJ Amiodarone Buspirone Diazepam Lovastatin Simvastatin

Amiodarone Amiodarone with GFJ increased – AUC by 50% – Maximum concentration by 84% Trial – Single dose – Healthy adults – Significant amount of GFJ Libersa CC et al J Clin Pharmacol. 49,

Buspirone Buspirone when taken with GFJ – AUC increased 9 fold – Peak concentration increased 4.3 fold – Time to peak concentration was delayed from 0.75 hours to 3 hours Trial – Run in phase of three days – Double strength GFJ used Lilja et al Clin Pharmacol Ther 1998;64:655-60

Buspirone Lilja et al Clin Pharmacol Ther 1998;64:655-60

Diazepam Use of diazepam and GFJ increased – AUC 3.2 fold – Maximum concentration 1.5 fold Trial facts – Small student – Unknown quantities of GFJ – Single dose Ozdemir M et al Eur J Drug Metab Pharmacokinet (1):55-9

Lovastatin Use of lovastatin and GFJ – With 2x strength 12 fold increase in peak concentration 15 fold increase in AUC – With 1x strength 1.3 fold increase in peak concentration 1.3 fold increase in AUC Kantola et al Clin Pharmacol Ther 1998; 63:397 – 402 Rogers et al Clin Pharmacol Ther 1999;66:358-66

Simvastatin Use of simvastatin and GFJ – With 2x strength GFJ 12 fold increase in peak serum concentration 13.5 fold increase in AUC – With 1x strength 3.9 fold increase in peak serum concentration 3.6 fold increase in AUC Lilja et al Clin Pharmacol Ther 2000; 68: Lilja et al Br J Clin Pharacol (1):56- 60

Parting thoughts Drugs to be probably concerned about – Atorvastatin 1.4 AUC increase, 1.6 Conc increase – Fexofenadine 30% reduction in bioavailability Fukazawa et al Br J Clin Pharmacol 57(4) Banfield et al Clin Pharmacokinet 41(4):